Red Nucleus (backed by The Riverside Company) Acquires Life Science Training Institute (LSTI)

THL Partners Acquires Majority Stake in Red Nucleus from The Riverside Company

October 17, 2024

Healthcare Services

THL Partners (Thomas H. Lee Partners) has made a majority investment in Red Nucleus, a Yardley, Pennsylvania-based provider of medical communications, market access, learning & development, and R&D support for the life sciences industry. The Riverside Company sold its investment in Red Nucleus; the deal closed October 17, 2024 and will support expansion of Red Nucleus’ commercialization services under new CEO Mike Menta and continued involvement from founder Ian Kelly.

Red Nucleus Acquires Jupiter Life Science Consulting

September 12, 2022

Consulting

Red Nucleus, a Riverside-backed life sciences services platform, has acquired Jupiter Life Science Consulting, a boutique provider of market access and commercialization strategies for pharma, biotech, and medical device clients. The add-on expands Red Nucleus's commercial and market-access capabilities, bringing Jupiter's expertise in payer research, pricing and access strategy, and commercialization planning into the combined platform.

Riverside's Red Nucleus Adds Actando SA

June 13, 2022

Healthcare Services

The Riverside Company’s Red Nucleus platform has completed an add-on acquisition of Actando SA, a Switzerland-headquartered provider of technology-enabled learning solutions for life sciences commercial teams. The deal expands Red Nucleus’ learning product portfolio and European footprint, strengthening its offering of scalable LMS, eLearning content and decision-making tools for global biopharma customers.

Red Nucleus (Riverside-backed) Acquires iTakeControl

March 4, 2021

Healthcare Services

Red Nucleus, a Riverside-backed provider of learning and performance solutions for life sciences, has acquired iTakeControl, a mobile platform that collects patient-reported outcomes and real-world data for virtual and home-based clinical trials. The transaction, announced in March 2021, is an add-on to Riverside’s Red Nucleus platform to expand virtual clinical trial and SaaS capabilities for rare disease and specialty pharma clients.

Red Nucleus / Riverside Acquire INVIVO Communications

September 30, 2020

Healthcare Services

Red Nucleus, the life-sciences learning and performance platform backed by The Riverside Company, acquired Toronto-based INVIVO Communications, a digital scientific communications agency. The deal is an add-on to Riverside's Red Nucleus platform, expanding RN's medical communications and digital scientific communications capabilities; the combined business now totals 360+ employees across seven locations.

The Riverside Company Acquires Red Nucleus from Renovus Capital Partners

March 24, 2020

Education

The Riverside Company has acquired Red Nucleus Enterprises, LLC, a Yardley, Pennsylvania-based provider of digital learning and regulatory compliance services for the life sciences industry. Renovus Capital Partners sold the company to Riverside but retained a minority equity stake and will continue to support future growth; Riverside plans to expand Red Nucleus's training offerings, technology capabilities and pursue add-on acquisitions.